Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy

clinical trial

Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT03418324

P6099clinical trial phasephase II clinical trialQ42824440
P17countryUnited States of AmericaQ30
P582end time2020-01-01
P921main subjectmetastatic prostate carcinomaQ55779807
P2899minimum age18
P1132number of participants40
P6153research siteCedars-Sinai Medical CenterQ1052562
P859sponsorCedars-Sinai Medical CenterQ1052562
P580start time2018-03-05
P8363study typeinterventional studyQ78089383
P1476titleA Phase 2 Study of TRC105 (Anti-endoglin Antibody) With Abiraterone and With Enzalutamide in Metastatic, Castration Resistant Prostate Cancer Patients Progressing on Therapy

Search more.